One study found that the CD39high Treg subpopulation derived from CRC patients reduced CD4+ and CD8+ T cell transendothelial migration (TEM), whereas CD39high Tregs derived from healthy volunteers did not exert these effects on TEM. Here, CD8A is linked to colorectal carcinoma.